Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Lancet

Volumn 365, Issue 9464, 2005, Pages 1054-1061

  Baxter, E Joanna ^a   Scott, Linda M ^a   Campbell, Peter J ^a   East, Clare ^b   Fourouclas, Nasios ^a   Swanton, Soheila ^a   Vassiliou, George S ^a   Bench, Anthony J ^b   Boyd, Elaine M ^b   Curtin, Natasha ^b   Scott, Mike A ^b   Erber, Wendy N ^b   Avis, Tim ^d   Barthorpe, Andy ^d   Bignell, Graham ^d   Blow, Matthew ^d   Brackenbury, Lisa ^d   Buck, Gemma ^d   Clegg, Sheila ^d   Clements, Jody ^d   Cole, Jennifer ^d   Davies, Helen ^d   Edkins, Sarah ^d   Gray, Kristian ^d   Gorton, Matthew ^d   O'Meara, Sarah ^d   Halliday, Kelly ^d   Harrison, Rachel ^d   Haynes, Wendy ^d   Hills, Katy ^d   Hunter, Chris ^d   Jones, David ^d   Kosmidou, Vivienne ^d   Laman, Ross ^d   Lugg, Richard ^d   Parker, Adrian ^d   Perry, Janet ^d   Petty, Robert ^d   Small, Alexandra ^d   Solomon, Helen ^d   Stephens, Philip ^d   Stephens, Yvonne ^d   Stevens, Claire ^d   Smith, Raffaella ^d   Tarpey, Patrick ^d   Tofts, Calli ^d   Varian, Jennifer ^d   West, Sofie ^d   Widaa, Sara ^d   Bamford, Sally ^d   Butler, Adam ^d   Dawson, Elizabeth ^d   Dicks, Ed ^d   Edwards, Ken ^d   Forbes, Simon ^d   Greenman, Chris ^d   Hinton, Jonathan ^d   Menzies, Andy ^d   Raine, Keiran ^d   Shepherd, Rebecca ^d   Teague, Jon ^d   Yates, Andrew ^d   Wooster, Richard ^d   Futreal, Andy ^d   Stratton, Mike ^d   Green, Anthony R ^a,b,c   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ERYTHROPOIETIN; JANUS KINASE 2; PHENYLALANINE; VALINE;

ADULT; ALLELE; AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; BONE MARROW CELL; CELL CULTURE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; ENZYME ACTIVITY; ERYTHROID CELL; EXON; FEMALE; GENETIC CODE; GRANULOCYTE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYPERSENSITIVITY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MITOTIC RECOMBINATION; MULTIPOTENT STEM CELL; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POINT MUTATION; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROTEIN DOMAIN; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; THROMBOCYTHEMIA;

EID: 20144363192     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)74230-6     Document Type: Article

References (36)

1. JL Spivak, G Barosi, G Tognoni Chronic myeloproliferative disorders Hematology (Am Soc Hematol Educ Program) 2003 200 224
2. JW Adamson, PJ Fialkow, S Murphy, JF Prchal, L Steinmann Polycythemia vera: stem-cell and probable clonal origin of the disease N Engl J Med 295 1976 913 916
3. PJ Fialkow, GB Faguet, RJ Jacobson, K Vaidya, S Murphy Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell Blood 58 1981 916 919
4. AR Green, GS Vassiliou, N Curtin, PJ Campbell Management of the myeloproliferative disorders: distinguishing data from dogma Hematol J 5 suppl 3 2004 S126 S132
5. RC Skoda Chronic myeloproliferative disorders: molecular markers and pathogenesis Hematol J 5 suppl 3 2004 S122 S125
6. JF Prchal, AA Axelrad Letter: bone marrow responses in polycythemia vera N Engl J Med 290 1974 1382
7. CH Dai, SB Krantz, EN Dessypris, RT Means, ST Horn, HS Gilbert Polycythemia vera II: hypersensitivity of bone marrow erythroid, granulocyte-macrophage and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony stimulating factor Blood 80 1992 891 899
8. Y Li, G Hetet, A-M Maurer, Y Chait, D Dhermy, J Briere Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF Br J Haematol 87 1994 471 476
9. S Kobayashi, M Teramura, S Hoshino, T Motoji, K Oshimi, H Mizoguchi Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3 Br J Haematol 83 1993 539 544
10. AA Axelrad, D Eskinazi, PN Correa, D Amato Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia Blood 96 2000 3310 3321
11. S Hinshelwood, AJ Bench, AR Green Pathogenesis of polycythaemia vera Blood Rev 11 1997 224 232
12. MW Deininger, JM Goldman, JV Melo The molecular biology of chronic myeloid leukemia Blood 96 2000 3343 3356
13. JT Reilly Receptor tyrosine kinases in normal and malignant haematopoiesis Blood Rev 17 2003 241 248
14. M Wadleigh, DJ DeAngelo, JD Griffin, RM Stone After chronic myelogenous leukaemia: tyrosine kinase inhibitors in other hematologic malignancies Blood 105 2005 22 30
15. E Komura, H Chagraoui, V Mansat de Mas Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression Exp Hematol 31 2003 622 630
16. U Ugo, C Marzac, I Teyssandier Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera Exp Hematol 32 2004 179 187
17. R Landolfi, R Marchioli, J Kutti Efficacy and safety of low-dose aspirin in polycythemia vera N Engl J Med 350 2004 114 124
18. TC Pearson Evaluation of diagnostic criteria in polycythemia vera Semin Hematol 38 1 suppl 2 2001 21 24
19. S Murphy, P Peterson, H Iland, J Laszlo Experience of the polycythemia vera study group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment Semin Hematol 34 1997 29 39
20. G Barosi, A Ambrosetti, C Finelli The Italian consensus conference on diagnostic criteria for myelofibrosis with myeloid metaplasia Br J Haematol 104 1999 730 737
21. AJ Bench, EP Nacheva, TL Hood Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes Oncogene 19 2000 3902 3913
22. W Dameshek Some speculations on the myeloproliferative syndromes Blood 6 1951 372 375
23. M Griesshammer, S Klippel, E Strunck PRV-1 mRNA expression discriminates two types of essential thrombocythemia Ann Hematol 83 2004 364 370
24. R Kralovics, RC Skoda Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders Blood Rev 19 2005 1 13
25. CN Harrison, AR Green Essential thrombocythemia Hematol Oncol Clin North Am 17 2003 1175 1190
26. R Kralovics, Y Guan, JT Prchal Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera Exp Hematol 30 2002 229 236
27. P Peeters, SD Raynaud, J Cools Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia Blood 90 1997 2535 2540
28. V Lacronique, A Boureux, V Valle A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia Science 278 1997 1309 1312
29. P Saharinen, K Takaluoma, O Silvennoinen Regulation of the Jak2 tyrosine kinase by its pseudokinase domain Mol Cell Biol 20 2000 3387 3395
30. P Saharinen, O Silvennoinen The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction J Biol Chem 277 2002 47954 47963
31. K Lindauer, T Loerting, KR Liedl, RT Kroemer Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation Protein Eng 14 2001 27 37
32. H Luo, P Rose, D Barber Mutation in the Jak kinase JH2 domain hyperactivates drosophila and mammalian Jak-Stat pathways Mol Cell Biol 17 1997 1562 1571
33. M Silva, C Richard, A Benito, C Sanz, I Olalla, JL Fernandez-Luna Expression of Bcl-x in erythroid precursors from patients with polycythemia vera N Engl J Med 338 1998 564 571
34. S Klippel, E Strunck, S Temerinac Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis Blood 102 2003 3569 3574
35. AR Moliterno, WD Hankins, JL Spivak Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera N Engl J Med 338 1998 572 580
36. F Gesbert, JD Griffin Bcr/Abl activates transcription of the Bcl-X gene through STAT5 Blood 96 2000 2269 2276